Immunotherapy is rapidly redefining the treatment landscape for gastric cancer—not only in metastatic settings, but now reaching into the neoadjuvant, perioperative, and even organ-preserving space. Across Asia, Europe, and the…

Immunotherapy is rapidly redefining the treatment landscape for gastric cancer—not only in metastatic settings, but now reaching into the neoadjuvant, perioperative, and even organ-preserving space. Across Asia, Europe, and the…